DeepRhythmAI vs Cardiomo

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Medicalgorithmics S.A.
VS
by Cardiomo, Inc.

AI Verdict

DeepRhythmAI is a cloud-based AI algorithm focused on highly accurate and efficient cardiac arrhythmia detection and classification from existing ECG data for clinical use. Cardiomo, while also utilizing AI for cardiovascular disease detection, centers around a medical-grade wearable device for continuous, remote heart health monitoring and real-time alerts for users and caregivers. Therefore, DeepRhythmAI is better suited for clinical ECG analysis workflows, while Cardiomo is designed for ongoing patient monitoring outside of a clinical setting.

Choose DeepRhythmAI if…

Choose DeepRhythmAI if your healthcare system requires an FDA-cleared, highly accurate, and efficient cloud-based AI solution for analyzing large volumes of ECG data from various devices. It is particularly well-suited for cardiology departments and health systems aiming to significantly reduce missed arrhythmia diagnoses and streamline clinical workflows for faster reporting and analysis.

View DeepRhythmAI →

Choose Cardiomo if…

Choose Cardiomo if you need a medical-grade wearable device and an AI-powered platform for continuous, remote heart health monitoring, especially for at-risk individuals or those requiring ongoing oversight. This tool is ideal for enabling real-time alerts to users and caregivers, facilitating early detection of cardiovascular events, and supporting telehealth initiatives for patient management at home.

View Cardiomo →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature DeepRhythmAI Cardiomo
Pricing Enterprise Contact for pricing
Deployment Cloud Cloud-based with wearable device and mobile app
FDA Status Cleared AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Cardiomo

Cardiomo offers a medical-grade wearable patch and a mobile application for continuous monitoring, providing real-time alerts and user-friendly information to patients, relatives, and caregivers. DeepRhythmAI, while powerful, is a cloud-based AI algorithm that lacks a direct user interface and requires integration with external visualization software for ECG technicians, making it less directly usable for patients or general practitioners without additional systems.

Clinical Value

DeepRhythmAI

DeepRhythmAI is an FDA-cleared algorithm that has demonstrated superior accuracy in cardiac arrhythmia detection, with a study showing 14 times fewer missed diagnoses of severe arrhythmias compared to human technicians. Cardiomo provides continuous vital sign monitoring and AI-powered disease detection, and has undergone clinical studies and obtained ISO 13485 certification, but specific comparative diagnostic accuracy data against established methods are not as extensively detailed as for DeepRhythmAI.

Pricing & Value

Tie

Both tools have opaque pricing models, with DeepRhythmAI listed as 'enterprise' and Cardiomo requiring contact for current pricing. While Cardiomo previously offered a consumer-oriented price, neither tool provides enough public detail to definitively assess comparative value.

Enterprise Readiness

DeepRhythmAI

DeepRhythmAI is designed for integration with various ECG devices and existing healthcare IT infrastructure via API, targeting a range of healthcare providers from solo practices to large health systems. Cardiomo, while HIPAA compliant and offering a cloud analytics system, is primarily centered around its proprietary wearable device, which may present more integration challenges for diverse enterprise environments.

Innovation

DeepRhythmAI

DeepRhythmAI utilizes advanced CNN and Transformer models trained on over 250 billion annotated heartbeats for superior accuracy and efficiency in ECG analysis, representing a significant leap in AI-powered diagnostics. Cardiomo's innovation lies in its medical-grade wearable for continuous remote monitoring and real-time alerts, which is a strong offering, but the core AI analysis for arrhythmia detection is a more established application of AI in cardiology.

Support & Docs

Tie

Neither the provided structured facts nor web searches offer sufficient specific information regarding the depth, availability, or quality of support and documentation for either DeepRhythmAI or Cardiomo to make a definitive judgment. Therefore, it is a tie.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature DeepRhythmAI Cardiomo
Name DeepRhythmAI Cardiomo
Company Medicalgorithmics S.A. Cardiomo, Inc.
Description FDA-cleared, cloud-based AI algorithm for cardiac arrhythmia detection and classification from ECG data. Medical-grade wearable device and AI-powered platform for continuous and remote heart health monitoring.
Key Features AI-powered arrhythmia detection and classification, utilizes CNN and Transformer models, trained on 250 billion+ annotated heartbeats, device-agnostic, cloud-based software, faster ECG reporting and analysis. Medical-grade wearable patch, continuous vital sign monitoring (ECG, heart rate, respiration, skin temperature), AI-powered disease detection, real-time alerts and notifications, mobile application (Android and iOS), fall detection, long battery life.

Videos

Demos, reviews, and walkthroughs featuring DeepRhythmAI and Cardiomo.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

DeepRhythmAI offers an API for integration with various ECG devices and can be integrated into existing healthcare workflows, including hospital information systems. Cardiomo, with its wearable device and mobile app, sends analyzed data to the cloud, which can then be accessed by healthcare providers. Effective EHR integration for cardiology often involves bi-directional data flow through HL7 FHIR APIs to connect clinical documentation and billing systems, removing manual data entry and automating CPT code capture.
DeepRhythmAI has demonstrated superior sensitivity for arrhythmia detection compared to human technicians, with one study showing 14 times fewer missed diagnoses of severe arrhythmias. It achieved a negative predictive value exceeding 99.9% for ruling out severe arrhythmias. Cardiomo's sensors achieve 99.2% clinical accuracy, validated through rigorous clinical studies, and its algorithms are trained to detect arrhythmias and other cardiac events. Wearable devices in general have shown sensitivity ranging from 84% to 95% and specificity up to 93% for arrhythmia detection.
DeepRhythmAI is designed to integrate seamlessly into existing equipment and software, suggesting a focus on ease of use within current clinical practices. Cardiomo is described as a user-friendly and practical system. While specific details on learning curves for these tools are not provided, AI-guided technology can facilitate cardiac imaging and shorten training for novice operators. Both companies would likely offer support, with Cardiomo's model potentially involving patient, relative, and care provider alerts.
DeepRhythmAI has ISO/IEC 27001 certification for information security management, which provides guidance for establishing, implementing, maintaining, and continually improving an information security management system. Cardiomo is HIPAA-compliant, and while specific additional certifications are not detailed, ISO 27001 is an international standard that highlights a vendor's commitment to protecting sensitive PHI. Strong security postures for healthcare IT applications typically include encryption, access controls, logging, backups, and incident response.
DeepRhythmAI's features include workflow automation to minimize manual reviews, implying a structured process that could incorporate audit trails. Cardiomo's system sends instant notifications and alerts to patients, relatives, and care providers, which would necessitate a record of these communications. Generally, robust audit trails are essential for identifying potential security breaches, investigating incidents, and complying with regulatory requirements, logging all user activities and actions on patient data.
DeepRhythmAI is designed for scalability across various healthcare organizations, from solo practices to large health systems, and can integrate with hospital information systems. Cardiomo's cloud-based platform and mobile app could support multi-site access for monitoring. For multi-location cardiology practices, shared protocols, unified billing, and per-site workflow configuration are important considerations. Seamless EHR integration and AI-driven automation are key for modernizing multi-site cardiology operations.
DeepRhythmAI is particularly suited for revolutionizing cardiac arrhythmia detection and classification from ECG data, offering superior accuracy and efficiency for physicians, and is device-agnostic, integrating with various ECG devices. It is intended for use by healthcare solution integrators to build web, mobile, or other electronically interfaced applications. Cardiomo, with its medical-grade wearable device, is designed for continuous and remote heart health monitoring, detecting cardiovascular diseases and providing timely alerts, making it suitable for ongoing patient monitoring, especially in geriatrics and internal medicine. DeepRhythmAI's focus on advanced ECG analysis makes it valuable for diagnostic precision in cardiology, while Cardiomo's wearable nature lends itself to remote patient monitoring and early detection in at-risk populations.

Backers

Who funded each tool's parent company.

Cardiomo

AI Tool Finder
AI-powered search. Results may not be comprehensive.